Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 58

1.

Insuring nanotech requires effective risk communication.

Murphy F, Mullins M, Hester K, Gelwick A, Scott-Fordsmand JJ, Maynard T.

Nat Nanotechnol. 2017 Aug 4;12(8):717-719. doi: 10.1038/nnano.2017.162. No abstract available.

PMID:
28775357
2.

Oxidative stress-driven parvalbumin interneuron impairment as a common mechanism in models of schizophrenia.

Steullet P, Cabungcal JH, Coyle J, Didriksen M, Gill K, Grace AA, Hensch TK, LaMantia AS, Lindemann L, Maynard TM, Meyer U, Morishita H, O'Donnell P, Puhl M, Cuenod M, Do KQ.

Mol Psychiatry. 2017 Jul;22(7):936-943. doi: 10.1038/mp.2017.47. Epub 2017 Mar 21.

3.

Foxd4 is essential for establishing neural cell fate and for neuronal differentiation.

Sherman JH, Karpinski BA, Fralish MS, Cappuzzo JM, Dhindsa DS, Thal AG, Moody SA, LaMantia AS, Maynard TM.

Genesis. 2017 Jun;55(6). doi: 10.1002/dvg.23031. Epub 2017 Apr 3.

4.

Balancing Act: Maintaining Amino Acid Levels in the Autistic Brain.

Maynard TM, Manzini MC.

Neuron. 2017 Feb 8;93(3):476-479. doi: 10.1016/j.neuron.2017.01.015.

5.

Neural transcription factors bias cleavage stage blastomeres to give rise to neural ectoderm.

Gaur S, Mandelbaum M, Herold M, Majumdar HD, Neilson KM, Maynard TM, Mood K, Daar IO, Moody SA.

Genesis. 2016 Jun;54(6):334-49. doi: 10.1002/dvg.22943. Epub 2016 May 3.

6.

Functional Divergence of the Nuclear Receptor NR2C1 as a Modulator of Pluripotentiality During Hominid Evolution.

Baker JL, Dunn KA, Mingrone J, Wood BA, Karpinski BA, Sherwood CC, Wildman DE, Maynard TM, Bielawski JP.

Genetics. 2016 Jun;203(2):905-22. doi: 10.1534/genetics.115.183889. Epub 2016 Apr 13.

7.

MicroRNAs Are Involved in the Development of Morphine-Induced Analgesic Tolerance and Regulate Functionally Relevant Changes in Serpini1.

Tapocik JD, Ceniccola K, Mayo CL, Schwandt ML, Solomon M, Wang BD, Luu TV, Olender J, Harrigan T, Maynard TM, Elmer GI, Lee NH.

Front Mol Neurosci. 2016 Mar 24;9:20. doi: 10.3389/fnmol.2016.00020. eCollection 2016.

8.

A cellular and molecular mosaic establishes growth and differentiation states for cranial sensory neurons.

Karpinski BA, Bryan CA, Paronett EM, Baker JL, Fernandez A, Horvath A, Maynard TM, Moody SA, LaMantia AS.

Dev Biol. 2016 Jul 15;415(2):228-241. doi: 10.1016/j.ydbio.2016.03.015. Epub 2016 Mar 15.

9.

Testicular receptor 2, Nr2c1, is associated with stem cells in the developing olfactory epithelium and other cranial sensory and skeletal structures.

Baker JL, Wood B, Karpinski BA, LaMantia AS, Maynard TM.

Gene Expr Patterns. 2016 Jan;20(1):71-9. doi: 10.1016/j.gep.2015.12.002. Epub 2015 Dec 19.

10.

Progressive Differentiation and Instructive Capacities of Amniotic Fluid and Cerebrospinal Fluid Proteomes following Neural Tube Closure.

Chau KF, Springel MW, Broadbelt KG, Park HY, Topal S, Lun MP, Mullan H, Maynard T, Steen H, LaMantia AS, Lehtinen MK.

Dev Cell. 2015 Dec 21;35(6):789-802. doi: 10.1016/j.devcel.2015.11.015.

11.

Hard to swallow: Developmental biological insights into pediatric dysphagia.

LaMantia AS, Moody SA, Maynard TM, Karpinski BA, Zohn IE, Mendelowitz D, Lee NH, Popratiloff A.

Dev Biol. 2016 Jan 15;409(2):329-42. doi: 10.1016/j.ydbio.2015.09.024. Epub 2015 Nov 7. Review.

12.

Modeling a model: Mouse genetics, 22q11.2 Deletion Syndrome, and disorders of cortical circuit development.

Meechan DW, Maynard TM, Tucker ES, Fernandez A, Karpinski BA, Rothblat LA, LaMantia AS.

Prog Neurobiol. 2015 Jul;130:1-28. doi: 10.1016/j.pneurobio.2015.03.004. Epub 2015 Apr 9. Review.

13.

Ranbp1, Deleted in DiGeorge/22q11.2 Deletion Syndrome, is a Microcephaly Gene That Selectively Disrupts Layer 2/3 Cortical Projection Neuron Generation.

Paronett EM, Meechan DW, Karpinski BA, LaMantia AS, Maynard TM.

Cereb Cortex. 2015 Oct;25(10):3977-93. doi: 10.1093/cercor/bhu285. Epub 2014 Dec 1.

14.

Microarray identification of novel genes downstream of Six1, a critical factor in cranial placode, somite, and kidney development.

Yan B, Neilson KM, Ranganathan R, Maynard T, Streit A, Moody SA.

Dev Dyn. 2015 Feb;244(2):181-210. doi: 10.1002/dvdy.24229. Epub 2014 Dec 16.

15.

Hectd1 is required for development of the junctional zone of the placenta.

Sarkar AA, Nuwayhid SJ, Maynard T, Ghandchi F, Hill JT, Lamantia AS, Zohn IE.

Dev Biol. 2014 Aug 15;392(2):368-80. doi: 10.1016/j.ydbio.2014.05.007. Epub 2014 May 20.

16.

Dysphagia and disrupted cranial nerve development in a mouse model of DiGeorge (22q11) deletion syndrome.

Karpinski BA, Maynard TM, Fralish MS, Nuwayhid S, Zohn IE, Moody SA, LaMantia AS.

Dis Model Mech. 2014 Feb;7(2):245-57. doi: 10.1242/dmm.012484. Epub 2013 Dec 19.

17.

Cognitive ability is associated with altered medial frontal cortical circuits in the LgDel mouse model of 22q11.2DS.

Meechan DW, Rutz HL, Fralish MS, Maynard TM, Rothblat LA, LaMantia AS.

Cereb Cortex. 2015 May;25(5):1143-51. doi: 10.1093/cercor/bht308. Epub 2013 Nov 11.

18.

On becoming neural: what the embryo can tell us about differentiating neural stem cells.

Moody SA, Klein SL, Karpinski BA, Maynard TM, Lamantia AS.

Am J Stem Cells. 2013 Jun 30;2(2):74-94. Print 2013.

19.

Cxcr4 regulation of interneuron migration is disrupted in 22q11.2 deletion syndrome.

Meechan DW, Tucker ES, Maynard TM, LaMantia AS.

Proc Natl Acad Sci U S A. 2012 Nov 6;109(45):18601-6. doi: 10.1073/pnas.1211507109. Epub 2012 Oct 22.

20.

22q11 Gene dosage establishes an adaptive range for sonic hedgehog and retinoic acid signaling during early development.

Maynard TM, Gopalakrishna D, Meechan DW, Paronett EM, Newbern JM, LaMantia AS.

Hum Mol Genet. 2013 Jan 15;22(2):300-12. doi: 10.1093/hmg/dds429. Epub 2012 Oct 16.

21.

Exome sequencing and functional validation in zebrafish identify GTDC2 mutations as a cause of Walker-Warburg syndrome.

Manzini MC, Tambunan DE, Hill RS, Yu TW, Maynard TM, Heinzen EL, Shianna KV, Stevens CR, Partlow JN, Barry BJ, Rodriguez J, Gupta VA, Al-Qudah AK, Eyaid WM, Friedman JM, Salih MA, Clark R, Moroni I, Mora M, Beggs AH, Gabriel SB, Walsh CA.

Am J Hum Genet. 2012 Sep 7;91(3):541-7. doi: 10.1016/j.ajhg.2012.07.009.

22.

The cerebrospinal fluid provides a proliferative niche for neural progenitor cells.

Lehtinen MK, Zappaterra MW, Chen X, Yang YJ, Hill AD, Lun M, Maynard T, Gonzalez D, Kim S, Ye P, D'Ercole AJ, Wong ET, LaMantia AS, Walsh CA.

Neuron. 2011 Mar 10;69(5):893-905. doi: 10.1016/j.neuron.2011.01.023.

23.

A Cys-loop mutation in the Caenorhabditis elegans nicotinic receptor subunit UNC-63 impairs but does not abolish channel function.

Jones AK, Rayes D, Al-Diwani A, Maynard TP, Jones R, Hernando G, Buckingham SD, Bouzat C, Sattelle DB.

J Biol Chem. 2011 Jan 28;286(4):2550-8. doi: 10.1074/jbc.M110.177238. Epub 2010 Oct 21.

24.

Three phases of DiGeorge/22q11 deletion syndrome pathogenesis during brain development: patterning, proliferation, and mitochondrial functions of 22q11 genes.

Meechan DW, Maynard TM, Tucker ES, LaMantia AS.

Int J Dev Neurosci. 2011 May;29(3):283-94. doi: 10.1016/j.ijdevneu.2010.08.005. Epub 2010 Sep 15. Review.

25.

Comt1 genotype and expression predicts anxiety and nociceptive sensitivity in inbred strains of mice.

Segall SK, Nackley AG, Diatchenko L, Lariviere WR, Lu X, Marron JS, Grabowski-Boase L, Walker JR, Slade G, Gauthier J, Bailey JS, Steffy BM, Maynard TM, Tarantino LM, Wiltshire T.

Genes Brain Behav. 2010 Nov;9(8):933-46. doi: 10.1111/j.1601-183X.2010.00633.x.

26.

Proliferative and transcriptional identity of distinct classes of neural precursors in the mammalian olfactory epithelium.

Tucker ES, Lehtinen MK, Maynard T, Zirlinger M, Dulac C, Rawson N, Pevny L, Lamantia AS.

Development. 2010 Aug 1;137(15):2471-81. doi: 10.1242/dev.049718. Epub 2010 Jun 23.

27.

Specific mesenchymal/epithelial induction of olfactory receptor, vomeronasal, and gonadotropin-releasing hormone (GnRH) neurons.

Rawson NE, Lischka FW, Yee KK, Peters AZ, Tucker ES, Meechan DW, Zirlinger M, Maynard TM, Burd GB, Dulac C, Pevny L, LaMantia AS.

Dev Dyn. 2010 Jun;239(6):1723-38. doi: 10.1002/dvdy.22315.

28.

Developmental and degenerative features in a complicated spastic paraplegia.

Manzini MC, Rajab A, Maynard TM, Mochida GH, Tan WH, Nasir R, Hill RS, Gleason D, Al Saffar M, Partlow JN, Barry BJ, Vernon M, LaMantia AS, Walsh CA.

Ann Neurol. 2010 Apr;67(4):516-25. doi: 10.1002/ana.21923.

29.

The ecological research needs of business.

Armsworth PR, Armsworth AN, Compton N, Cottle P, Davies I, Emmett BA, Fandrich V, Foote M, Gaston KJ, Gardiner P, Hess T, Hopkins J, Horsley N, Leaver N, Maynard T, Shannon D.

J Appl Ecol. 2010 Apr;47(2):235-243.

30.

A horizon scan of global conservation issues for 2010.

Sutherland WJ, Clout M, Côté IM, Daszak P, Depledge MH, Fellman L, Fleishman E, Garthwaite R, Gibbons DW, De Lurio J, Impey AJ, Lickorish F, Lindenmayer D, Madgwick J, Margerison C, Maynard T, Peck LS, Pretty J, Prior S, Redford KH, Scharlemann JP, Spalding M, Watkinson AR.

Trends Ecol Evol. 2010 Jan;25(1):1-7. doi: 10.1016/j.tree.2009.10.003. Epub 2009 Nov 26.

PMID:
19939492
31.

Beyond regulation: risk pricing and responsible innovation.

Owen R, Baxter D, Maynard T, Depledge M.

Environ Sci Technol. 2009 Sep 15;43(18):6902-6. No abstract available.

PMID:
19806718
32.

Diminished dosage of 22q11 genes disrupts neurogenesis and cortical development in a mouse model of 22q11 deletion/DiGeorge syndrome.

Meechan DW, Tucker ES, Maynard TM, LaMantia AS.

Proc Natl Acad Sci U S A. 2009 Sep 22;106(38):16434-45. doi: 10.1073/pnas.0905696106. Epub 2009 Sep 10.

33.

Mitochondrial localization and function of a subset of 22q11 deletion syndrome candidate genes.

Maynard TM, Meechan DW, Dudevoir ML, Gopalakrishna D, Peters AZ, Heindel CC, Sugimoto TJ, Wu Y, Lieberman JA, Lamantia AS.

Mol Cell Neurosci. 2008 Nov;39(3):439-51. doi: 10.1016/j.mcn.2008.07.027. Epub 2008 Aug 15.

34.

When half is not enough: gene expression and dosage in the 22q11 deletion syndrome.

Meechan DW, Maynard TM, Gopalakrishna D, Wu Y, LaMantia AS.

Gene Expr. 2007;13(6):299-310. Review.

PMID:
17708416
35.

Gene dosage in the developing and adult brain in a mouse model of 22q11 deletion syndrome.

Meechan DW, Maynard TM, Wu Y, Gopalakrishna D, Lieberman JA, LaMantia AS.

Mol Cell Neurosci. 2006 Dec;33(4):412-28. Epub 2006 Nov 13.

PMID:
17097888
36.

No evidence for parental imprinting of mouse 22q11 gene orthologs.

Maynard TM, Meechan DW, Heindel CC, Peters AZ, Hamer RM, Lieberman JA, LaMantia AS.

Mamm Genome. 2006 Aug;17(8):822-32. Epub 2006 Aug 4.

37.

Limited influence of olanzapine on adult forebrain neural precursors in vitro.

Councill JH, Tucker ES, Haskell GT, Maynard TM, Meechan DW, Hamer RM, Lieberman JA, LaMantia AS.

Neuroscience. 2006 Jun 19;140(1):111-22. Epub 2006 Mar 29.

PMID:
16564641
38.

A comprehensive analysis of 22q11 gene expression in the developing and adult brain.

Maynard TM, Haskell GT, Peters AZ, Sikich L, Lieberman JA, LaMantia AS.

Proc Natl Acad Sci U S A. 2003 Nov 25;100(24):14433-8. Epub 2003 Nov 12.

39.

Mesenchymal/epithelial regulation of retinoic acid signaling in the olfactory placode.

Bhasin N, Maynard TM, Gallagher PA, LaMantia AS.

Dev Biol. 2003 Sep 1;261(1):82-98.

40.

Retinoic acid signaling at sites of plasticity in the mature central nervous system.

Thompson Haskell G, Maynard TM, Shatzmiller RA, Lamantia AS.

J Comp Neurol. 2002 Oct 21;452(3):228-41.

PMID:
12353219
41.

22q11 DS: genomic mechanisms and gene function in DiGeorge/velocardiofacial syndrome.

Maynard TM, Haskell GT, Lieberman JA, LaMantia AS.

Int J Dev Neurosci. 2002 Jun-Aug;20(3-5):407-19. Review.

PMID:
12175881
42.

RanBP1, a velocardiofacial/DiGeorge syndrome candidate gene, is expressed at sites of mesenchymal/epithelial induction.

Maynard TM, Haskell GT, Bhasin N, Lee JM, Gassman AA, Lieberman JA, LaMantia AS.

Mech Dev. 2002 Feb;111(1-2):177-80.

43.

High-resolution mapping of the Gli3 mutation extra-toes reveals a 51.5-kb deletion.

Maynard TM, Jain MD, Balmer CW, LaMantia AS.

Mamm Genome. 2002 Jan;13(1):58-61. No abstract available.

PMID:
11773971
44.

Neural development, cell-cell signaling, and the "two-hit" hypothesis of schizophrenia.

Maynard TM, Sikich L, Lieberman JA, LaMantia AS.

Schizophr Bull. 2001;27(3):457-76. Review.

PMID:
11596847
45.
46.
47.

Avian transitin expression mirrors glial cell fate restrictions during neural crest development.

Henion PD, Blyss GK, Luo R, An M, Maynard TM, Cole GJ, Weston JA.

Dev Dyn. 2000 May;218(1):150-9.

48.
49.

From the borders: reforming the curriculum for the at-risk student.

Tayebi K, Moore-Jazayeri M, Maynard T.

J Cult Divers. 1998 Fall;5(3):101-9.

PMID:
10025303
50.

Glial domains and axonal reordering in the chiasmatic region of the developing ferret.

Reese BE, Maynard TM, Hocking DR.

J Comp Neurol. 1994 Nov 8;349(2):303-24.

PMID:
7860785

Supplemental Content

Loading ...
Support Center